The Impact of Rosiglitazone on Regression of Atherosclerosis

Clinical trial NCT00166803 · SUSPENDED

Trial details

NCT number: NCT00166803
Sponsor: National Taiwan University Hospital
Status: SUSPENDED
Phase: Not Applicable
Study type: INTERVENTIONAL

Diabetes Mellitus, Atherosclerosis

Start date: 2005-06-01
Primary completion: 2008-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.